These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5818829)

  • 1. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    Shanbrom E; Thelin GM
    JAMA; 1969 Jun; 208(10):1853-6. PubMed ID: 5818829
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryoprecipitate therapy in haemophilia.
    Forbes CD; Hunter J; Barr RD; Davidson JF; Short DW; McDonald GA; McNicol GP; Wallace J; Douglas AS
    Scott Med J; 1969 Jan; 14(1):1-9. PubMed ID: 5304824
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 4. A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.
    Brinkhous KM; Shanbrom E; Roberts HR; Webster WP; Fekete L; Wagner RH
    JAMA; 1968 Aug; 205(9):613-7. PubMed ID: 5695099
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L; Frenkel EP
    Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
    [No Abstract]   [Full Text] [Related]  

  • 6. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cryoprecipitates rich in factor VIII. In vitro and in vivo studies].
    Parquet-Gernez A; Bauters F
    Rev Fr Transfus; 1969 Dec; 12(4):439-50. PubMed ID: 5310871
    [No Abstract]   [Full Text] [Related]  

  • 8. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
    Kuble M; Wegner H; Cron D
    Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryoprecipitate concentrates of factor 8 for surgery in hemophiliacs.
    Cooke JV; Holland PV; Shulman NR
    Ann Intern Med; 1968 Jan; 68(1):39-47. PubMed ID: 5635330
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hemophilia with glycine-precipitated factor 8.
    Abildgaard CF; Simone JV; Corrigan JJ; Seeler RA; Edelstein G; Vanderheiden J; Schulman I
    N Engl J Med; 1966 Sep; 275(9):471-5. PubMed ID: 5917942
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
    Berndtsson M; Zetterberg E; Holmström M; Mahmoud Hourani Soutari N; Mikovic D; Elezovic I; Antovic JP
    Thromb Res; 2016 Aug; 144():133-5. PubMed ID: 27331346
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemostatic response to factor VIII administration in patients with haemophilia A measured by thrombin generation and correlation with factor concentrate use.
    Hugenholtz GC; Luddington R; Baglin T
    Haemophilia; 2016 Jan; 22(1):e42-5. PubMed ID: 26388112
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis in haemophilia.
    Lancet; 1971 Jan; 1(7690):118-9. PubMed ID: 4099608
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of hemorrhage in patients with hemophilia].
    Pliushch OP; Rutberg RA; Zakhrova NS; Shefter LI
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):11-3. PubMed ID: 1273055
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract].
    Brühl P; Weibbach L; Brackmann HH
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):401-4. PubMed ID: 804604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
    Brackmann HH; Gormsen J
    Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substitutive treatment of hemopjolia A using a new factor VIII concentrate].
    Allain JP; Steinbuch M; Meunier L; Muller JY; Soulier JP
    Nouv Presse Med; 1976 Apr; 5(16):1047-50. PubMed ID: 1272773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human factor VIII prepared by cryoprecipitation.
    Masure R
    Vox Sang; 1969 Jan; 16(1):1-9. PubMed ID: 5766099
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
    Bloom AL; Emmanuel JH
    Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
    [No Abstract]   [Full Text] [Related]  

  • 20. Pre-assayed AHF concentrate therapy for hemophilia.
    Peterson CA; Borucki DT; Austin G
    Bibl Haematol; 1968; 29():1160-5. PubMed ID: 5303858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.